Alan Mattamana

Mr. Mattamana is a Partner at Fairview Capital and a member of its Investment Committee. He is involved in investment selection, deal execution and monitoring activities for Fairview’s venture capital and private equity direct co-investment and partnership portfolios. Mr. Mattamana represents Fairview on direct investments including Rallybio (NASDAQ: RLBY), eVariant (acquired by Healthgrades), Device42, Covr Financial, Inbox Health, and 365 Datacenters, and serves on a number of advisory boards of venture capital and private equity partnerships.

Prior to joining Fairview in 2009, Mr. Mattamana was a Principal with Polaris Venture Partners, a diversified venture capital firm. At Polaris, he focused on venture capital investments in the software, digital media, consumer, medical technology, and healthcare services sectors. He was involved in several successful investments including Q1 Labs, Archivas and Turbine Entertainment, and served as board observer to portfolio companies including Advion BioSciences and GI Dynamics. Previously, Mr. Mattamana was a strategy consultant at McKinsey & Co, where he served clients in the software, telecommunications and aerospace sectors in the firm’s Silicon Valley office. He also has prior experience at NASA, Goldman Sachs, and Neuberger Berman.

Mr. Mattamana graduated from Princeton University with a B.S.E in Chemical Engineering, and earned an MBA from Harvard Business School. He serves on The Hartford Foundation for Public Giving’s Impact! Fund, and the Board of Connecticut Health and Education Facilities Authority (CHEFA).